Announcements Trials
Browse Landscape

Phase

Phase 2 56Phase 1/2 28Phase 3 22Phase 1 19Phase EARLY_PHASE1 4Phase 4 2Phase 2/3 1

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Gynecologic 1Genitourinary 1

Conditions

Glioblastoma 2Urinary Bladder Neoplasms 1Glioma 1Endometrial Endometrioid Adenocarcinoma 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 26pembrolizumab 17Radiotherapy 17Specimen Handling 16Nivolumab 15Cyclophosphamide 14Temozolomide 11Biopsy 11fludarabine 9Fluorodeoxyglucose F18 9X-Rays 8Etoposide 7Bevacizumab 7Standard of Care 6Radiation 6Paclitaxel 6Dexamethasone 6Cisplatin 6Carboplatin 6Surgical Procedures, Operative 5Ipilimumab 5Doxorubicin 5Aspirin 5venetoclax 4fluciclovine F-18 4atezolizumab 4abemaciclib 4Vincristine 4Rituximab 4Radiosurgery 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × abemaciclib × 1 year × Clear all
NCT04391595 2026-03-06

LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients

St. Joseph's Hospital and Medical Center, Phoenix

Phase EARLY_PHASE1 Completed
42 enrolled
CNS

Glioblastoma, Glioma

NCT03837821 2025-11-18

CLONEVO

Weill Medical College of Cornell University

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT04049227 2025-10-20

Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer

Northwestern University

Phase EARLY_PHASE1 Completed
27 enrolled
Gynecologic

Endometrial Endometrioid Adenocarcinoma

NCT04074785 2025-08-17

SCCC-06319

University of Texas Southwestern Medical Center

Phase EARLY_PHASE1 Terminated
10 enrolled
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡